The New Director of Medicinal Plants Research Institute of Iranian Academic Center for Education, Culture and Research (ACECR), appointed

In a ceremony, Dr. Rezazadeh was assigned as the new director of the Medicinal Plants Institute of ACECR Research Complex .

This ceremony was attended by the Research Deputy of ACECR, Dr. Amin Esmaeili, and Mr. Rabbani, the director of Alborz Province Science and Technology Park and the staff of this research institute.

In a speech, Dr. Amin Esmaeili expressed his appreciation for the efforts and services of the former director of this research institute, Dr. Naghdi, and added, “This institute, which has been established since 1999, is indebted to the previous researchers and thinkers during these past years, and it is one of the main institutes in the ACECR, since there is a promising future in the field of medicinal plants and the country’s needs are to be satisfied in this regard.”

Amin Esmaeili highlighted the conversion of research results to technology and commercialization and added, ” we must present the know-how as our product.”

The former director of the Medicinal Plants Research Institute, Dr. Naghdi, also delivered a speech in this ceremony and expressed hope that during the new management, the activities should rise in a way that this institute would bring honor for the country as well as for the ACECR.

“During these past years, we developed infrastructures where necessary, and now these infrastructures of the institute are ready to be exploited.” He further noted.

The new director of the institute, Dr. Rezazadeh, also expressed his happiness for his presence in Medicinal Plants Research Institute and said, “The research institute needs to have more value added, which together with a proper condition, infrastructures and the number of scientific staff present at the institute, suitable activities could be carried out.”

In the end, he pointed out the future prospect of this institute as the following: new planning for research in traditional medicine, manufacturing of drugs and drug-related products, clinical pharmacy and the establishment of knowledge-based companies.

Source: ISNA